CCR5 and cancer: Building on prior work showing that moDCs induce regulatory T cells in allergic and cancer settings13, 31, we show that transient inhibition of CCR5, required for monocyte lymph node migration, enhances the efficacy of neoantigen-based cancer vaccination.